1.On the Degranulation of Mesenteric Mast Cells Caused by Morphine and Meperidine Hydrochloride in White Rats.
Yonsei Medical Journal 1969;10(2):153-161
Histological studies were carried out on the degranulation of mesenteric mast cells of white rats caused by injections of morphine hydrochbride and meperidine hydrochbride intravenously, intraperitoneally, and by local injection of the rat's mesentery and the following conclusions were obtained. 1. In the groups of intravenous, intraperitoneal, and local injections of morphine hydrochloride, fairly significant degranulation of the mesenteric mast cell was observed, which was probably associated with the concomitant liberation of tissue histamine derived from its source. 2. In the groups of intravenous and intraperitoneal injections of meperidine hydrochbride, the significant degranulation of the mesenteric mast ,cell was recognized. However, the local injections displayed no cytological change of the cell and no increased permeability of dermal capillaries was observed at the injecting site. 3. The degranulation of the mesenteric mast cell followed by an administration of meperidine hydrochloride was effectively inhibited after an adrenalectomy.
Animals
;
Female
;
Male
;
Mast Cells/*drug effects
;
Meperidine/*adverse effects
;
Mesentery/drug effects/*pathology
;
Morphine/*adverse effects
;
Rats
2.IFN-γ secretion in gut of Ob/Ob mice after vertical sleeve gastrectomy and its function in weight loss mechanism.
Jin-Peng DU ; Geng WANG ; Chao-Jie HU ; Qing-Bo WANG ; Hui-Qing LI ; Wen-Fang XIA ; Xiao-Ming SHUAI ; Kai-Xiong TAO ; Guo-Bin WANG ; Ze-Feng XIA
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(3):377-382
Vertical sleeve gastrectomy (VSG) is becoming more and more popular among the world. Despite its dramatic efficacy, however, the mechanism of VSG remains largely undetermined. This study aimed to test interferon (IFN)-γ secretion n of mesenteric lymph nodes in obese mice (ob/ob mice), a model of VSG, and its relationship with farnesoid X receptor (FXR) expression in the liver and small intestine, and to investigate the weight loss mechanism of VSG. The wild type (WT) mice and ob/ob mice were divided into four groups: A (WT+Sham), B (WT+VSG), C (ob/ob+Sham), and D (ob/ob+VSG). Body weight values were monitored. The IFN-γ expression in mesenteric lymph nodes of ob/ob mice pre- and post-operation was detected by flow cytometry (FCM). The FXR expression in the liver and small intestine was detected by Western blotting. The mouse AML-12 liver cells were stimulated with IFN-γ at different concentrations in vitro. The changes of FXR expression were also examined. The results showed that the body weight of ob/ob mice was significantly declined from (40.6±2.7) g to (27.5±3.8) g on the 30th day after VSG (P<0.05). At the same time, VSG induced a higher level secretion of IFN-γ in mesenteric lymph nodes of ob/ob mice than that pre-operation (P<0.05). The FXR expression levels in the liver and small intestine after VSG were respectively 0.97±0.07 and 0.84±0.07 fold of GAPDH, which were significantly higher than pre-operative levels of 0.50±0.06 and 0.48±0.06 respectively (P<0.05). After the stimulation of AML-12 liver cells in vitro by different concentrations of IFN-γ (0, 10, 25, 50, 100, and 200 ng/mL), the relative FXR expression levels were 0.22±0.04, 0.31±0.04, 0.39±0.05, 0.38±0.05, 0.56±0.06, and 0.35±0.05, respectively, suggesting IFN-γ could distinctly promote the FXR expression in a dose-dependent manner in comparison to those cells without IFN-γ stimulation (P<0.05). It was concluded that VSG induces a weight loss in ob/ob mice by increasing IFN-γ secretion of mesenteric lymph nodes, which then increases the FXR expression of the liver and small intestine.
Animals
;
Body Weight
;
Cell Line
;
Gastrectomy
;
methods
;
Gene Expression
;
Hepatocytes
;
cytology
;
drug effects
;
metabolism
;
Interferon-gamma
;
biosynthesis
;
pharmacology
;
secretion
;
Intestine, Small
;
drug effects
;
metabolism
;
Liver
;
drug effects
;
metabolism
;
Lymph Nodes
;
drug effects
;
metabolism
;
Mesentery
;
drug effects
;
metabolism
;
Mice
;
Mice, Obese
;
Obesity
;
metabolism
;
pathology
;
surgery
;
Receptors, Cytoplasmic and Nuclear
;
agonists
;
genetics
;
metabolism
;
Weight Loss